Provided by Tiger Trade Technology Pte. Ltd.

Pfizer

27.65
-0.1300-0.47%
Post-market: 27.660.0140+0.05%19:28 EDT
Volume:28.81M
Turnover:793.80M
Market Cap:157.21B
PE:36.39
High:27.75
Open:27.69
Low:27.40
Close:27.78
52wk High:29.21
52wk Low:23.58
Shares:5.69B
Float Shares:5.64B
Volume Ratio:0.96
T/O Rate:0.51%
Dividend:1.72
Dividend Rate:6.22%
EPS(TTM):0.7599
EPS(LYR):1.36
ROE:5.01%
ROA:5.78%
PB:1.85
PE(LYR):20.27

Loading ...

Top News Today/Canada: WestJet Strike Grounds Hundreds of Flights in Canada

Dow Jones
·
Aug 04

Pfizer’s Quiet Pipeline Push Could Ignite PFE Rally

TIPRANKS
·
Aug 01

Moderately bullish activity in Pfizer with shares up 0.46%

TIPRANKS
·
Aug 01

LITFULO Vitiligo Win And New COVID Shot Could Be A Game Changer For Pfizer (PFE)

Simply Wall St.
·
Jul 31

Pfizer’s Symbiotic-Lung-10 Trial: A Fresh Lung Cancer Bet with Pipeline Upside for PFE

TIPRANKS
·
Jul 31

Pfizer Prepares Global Regulatory Litfulo Filings Following Skin Pigment Improvements In Late-Stage Trials

Benzinga_recent_news
·
Jul 31

Pfizer's Litfulo Achieves Primary Goal in Vitiligo Study

Deep News
·
Jul 30

Pfizer's Litfulo Hits Endpoints in Nonsegmental Vitiligo Studies

Dow Jones
·
Jul 30

Pfizer's Oral Drug Restores Skin Pigmentation in Late-stage Vitiligo Trials

Reuters
·
Jul 30

Pfizer - More Patients on Litfulo Achieve F-Vasi75 and T-Vasi50 at Week 52 Versus Placebo

THOMSON REUTERS
·
Jul 30

Pfizer: Plans to Initiate Pivotal Study Evaluating Litfulo for Treatment of Moderate Alopecia Areata in 2026

THOMSON REUTERS
·
Jul 30

Pfizer - to Submit Global Regulatory Filings for Litfulo in Nonsegmental Vitiligo

THOMSON REUTERS
·
Jul 30

Pfizer - Litfulo Safety Profile in Nsv Consistent with Prior Data; no New Safety Signals

THOMSON REUTERS
·
Jul 30

Pfizer Announces Positive Topline Phase 3 Results for Litfulo in Patients with Nonsegmental Vitiligo

THOMSON REUTERS
·
Jul 30

Pfizer - Litfulo Phase 3 Studies Meet Co-Primary Endpoints at Week 52 in Vitiligo

THOMSON REUTERS
·
Jul 30

New York City has paused construction at several office-to-apartment conversions since Pfizer tower structural problems

CNN Business
·
Jul 30

NYC Officials Halt Construction at Third Manhattan Conversion Project

Dow Jones
·
Jul 30

BioNTech and Pfizer Secure EU Approval for XFG-Adapted COVID-19 Vaccine for 2026-2027 Season

TIPRANKS
·
Jul 30

Pfizer, BioNTech Updated Covid Vaccine Gets Europe Approval

Dow Jones
·
Jul 30

EU Authorizes Pfizer-BioNTech XFG-adapted COVID Vaccine for Ages 6 Months and Up

Reuters
·
Jul 30